203
Participants
Start Date
February 15, 2016
Primary Completion Date
November 14, 2016
Study Completion Date
November 14, 2016
Estradiol Vaginal Capsule (EVC)
Administered intravaginally once daily for 2 weeks and then once weekly for 4 weeks
Placebo
Administered intravaginally once daily for 2 weeks and then once weekly for 4 weeks
Clinical Research of Philadelphia, LLC, Philadelphia
Virginia Women's Center, Richmond
Hawthorne Medical Research, Inc., Winston-Salem
Carolina Women's Research and Wellness Center, Durham
Fellows Research Alliance, Inc, Bluffton
Fellows Research Alliance, Inc, Savannah
Comprehensive Clinical Trials, LLC, West Palm Beach
Women's Medical Research Group, LLC, Clearwater
Radiant Research, Inc., Pinellas Park
Women's Health Research, Columbus
Rapid Medical Research, Inc., Cleveland
Beyer Research, Kalamazoo
Radiant Research, Inc., Dallas
Radiant Research, Inc., San Antonio
Visions Clinical Research-Tucson, Tucson
Office of R. Garn Mabey, M.D., Las Vegas
Genesis Center for Clinical Research, San Diego
Seattle Women's Health, Research, Gynecology, Seattle
North Spokane Women's Clinic, Spokane
Coastal Connecticut Research, LLC, New London
Lead Sponsor
Warner Chilcott
INDUSTRY